Evidence map›Paper›PMID 22008845›Full record

ReviewDer Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen2011

[Strategies for preoperative downsizing in patients with local nonresectable pancreatic cancer].

S E Combs, D Habermehl, J Werner, M W Büchler, J Debus

Abstract readReview
PubMed Publisher
In one paragraph

Review in Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Advanced-stage pancreatic cancer: therapy options.Nature reviews. Clinical oncology · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

S E CombsAbteilung RadioOnkologie und Strahlentherapie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland. Stephanie.Combs@med.uni-heidelberg.de
D Habermehl
J Werner
M W Büchler
J Debus
Heidelberg University · DEChirurgische Universitätsklinik Heidelberg · DEUniversitätsklinik für Strahlentherapie · DEUniversity Hospital Heidelberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In about 30-40% of all patients with pancreatic cancer a locally advanced lesion without distant metastases is found at primary diagnosis and the tumor is mostly nonresectable due to the close vicinity to blood vessels. Neoadjuvant treatment strategies, such as neoadjuvant radiochemotherapy offer the possibility to achieve substantial tumor reduction so that secondary resectability can be achieved. Therefore, treatment decisions should be made in an interdisciplinary context. In the future, innovative study protocols as well as novel radiation modalities, such as carbon ions can open new horizons in the treatment of this patient population. Additionally, molecular markers may help to stratify patients for different treatment schedules.

Indexed as

Neoadjuvant TherapyAntimetabolites, AntineoplasticChemoradiotherapyCombined Modality TherapyCooperative BehaviorDeoxycytidineDose Fractionation, RadiationGemcitabineHumansInterdisciplinary CommunicationNeoplasm StagingPancreatectomyPancreatic NeoplasmsParticle AcceleratorsPrognosisRadiotherapy, Intensity-ModulatedAntimetabolites, AntineoplasticDeoxycytidineGemcitabine

Identifiers

PMID22008845
OpenAlexW10948080

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.